Splenic diffuse red pulp small B-cell lymphoma: Revision of a series of cases reveals characteristic clinico-pathological features

Haematologica

Volumn 95, Issue 7, 2010, Pages 1122-1129

  Kanellis, George ^a   Mollejo, Manuela ^b   Montes Moreno, Santiago ^a   Rodriguez Pinilla, Socorro María ^a   Cigudosa, Juan C ^a   Algara, Patricia ^b   Montalban, Carlos ^c   Matutes, Estella ^d   Wotherspoon, Andrew ^d   Piris, Miguel A ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Leukemia; Splenic lymphoma; Villous cells

Indexed keywords

ANTIGEN; ANTINEOPLASTIC AGENT; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; FMC7 ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN H; LIPOCORTIN 1; PROTEIN BCL 6; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW BIOPSY; CANCER SURVIVAL; CASE STUDY; CELL INFILTRATION; CELL NUCLEUS; CELL SIZE; CHROMATIN; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOPLASM; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOMA CELL; MALE; OVERALL SURVIVAL; PATHOLOGICAL ANATOMY; RETROSPECTIVE STUDY; SPLENECTOMY; SPLENIC DIFFUSE RED PULP SMALL B CELL LYMPHOMA; SPLENOMEGALY; SURVIVAL RATE; SYMPTOM; BONE MARROW EXAMINATION; CLASSIFICATION; LYMPHOMA, B-CELL; MIDDLE AGED; PATHOLOGY; SPLENIC NEOPLASMS;

ADULT; AGED; BONE MARROW EXAMINATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPLENIC NEOPLASMS; SPLENOMEGALY; SURVIVAL RATE;

EID: 77954463374     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.013714     Document Type: Article

References (18)

1. Pins MA, Foucar KM, Mollejo M, Campo E, Falini B. Splenic lymphoma/leukemia, unclassifiable. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., eds. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. 4 ed. Lyon: IARC Press, 2008:191-203.
2. Mollejo M, Algara P, Mateo MS, Sanchez-Beato M, Lloret E, Medina MT, et al. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma¿ Histopathology 2002;40(1):22-30.
3. Papadaki T, Stamatopoulos K, Belessi C, Pouliou E, Parasi A, Douka V, et al. Splenic marginal-zone lymphoma: one or more entities¿ A histologic, immunohistochemi-cal, and molecular study of 42 cases. Am J Surg Pathol. 2007;31(3):438-446.
4. Traverse-Glehen A, Baseggio L, Bauchu EC, Morel D, Gazzo S, Ffrench M, et al. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity¿ Blood. 2008;111(4):2253-2260.
5. Ferreira BI, Garcia JF, Suela J, Mollejo M, Camacho FI, Carro A, et al. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica. 2008;93(5):670-689.
6. Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, Romero L, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood. 2002;99(4):1299-1304.
7. Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood. 2003; 101(7):2464-2472.
8. Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal- zone lymphoma. Semin Hematol. 1999;36(2):148-154.
9. Pittaluga S, Verhoef G, Criel A, Wlodarska I, Dierlamm J, Mecucci C, et al. Small B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis. Am J Surg Pathol. 1996;20(2):211-223.
10. Melo JV, Robinson DS, Gregory C, Catovsky D. Splenic B cell lymphoma with villous lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia. Leukemia. 1987;l(4):294-308.
11. Matutes E, Wotherspoon A, Catovsky D. The variant form of hairy-cell leukaemia. Best Pract Res Clin Haematol. 2003;16(1): 41-56.
12. Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia. 2008;22(3):487-495.
13. Franco V, Florena AM, Campesi G. Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma. Histopathology. 1996;29(6):571-585.
14. Falini B, Tiacci E, Liso A, Basso K, Sabattini E, Pacini R, et al. Simple diagnostic assay for hairy cell leukaemia by immunocyto-chemical detection of annexin Al (ANXA1). Lancet. 2004;363(9424):1869-1870.
15. Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D. p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood. 2001;97(11): 3552-3568.
16. Vallianatou K, Brito-Babapulle V, Matutes E, Atkinson S, Catovsky D. p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant. Leuk Res. 1999;23(11): 1041-1055.
17. Mateo M, Mollejo M, Villuendas R, Algara P, Sanchez-Beato M, Martinez P, et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol. 1999;154(5):1583-1599.
18. Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, Romero L, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood. 2002;99(4):1299-1304.